1. Introduction {#sec1-1}
===============

Diabetes Mellitus is a global chronic public health problem. The magnitude of this problem is expected to rise enormously with the predicted increase in its prevalence in the coming years. According to one estimate the number of adults suffering from diabetes is likely to more than double by 2025 from its existing number of 177 million ([@ref16]). The morbidity and mortality related to diabetes is a great global concern. The data from various studies has found diabetes as the growing cause of disability and premature death mainly through its chronic complications. Studies conducted in various countries have shown increased incidence of micro as well as the macro vascular complications among the diabetic patients. Diabetes mellitus is one of the major risk factors for cardio vascular diseases. Approximately 30% of patients treated in cardiovascular intensive care units have diabetes ([@ref11]). One study conducted in the central province of Saudi Arabia has found 24.1% of the diabetic patient suffering from cardiac ischemic disease. Diabetic retinopathy is fast emerging as the one of the commonest causes of blindness. According to WHO Diabetic retinopathy is the commonest cause of blindness among the working age group of the developed nation and over 2.5 million people are blind globally due to diabetes ([@ref12]). Recent studies conducted in central and eastern provinces of Saudi Arabia have found 34 and 31% of diabetic retinopathy among the diabetic patients ([@ref5]; [@ref12]). Diabetic nephropathy is similarly a serious complication of diabetes and affects 30-40% of all patients with diabetes ([@ref7]). In a clinic based study in Riyadh and a primary health care based study in Abha (Saudi Arabia), the researchers have found 41.3% and 12.8% of the diabetic patients suffering from frank proteinuria ([@ref9]; [@ref3]).

The incidence of cerebrovascular infarction has been found to be 2.5- to 3.5 fold greater in the diabetic population aged 45 to 74 years than in the non diabetic population ([@ref8]). In a hospital study conducted in Riyadh researchers have found a prevalence of 17.6% of stroke among the diabetics attending the hospital while in a population based study in UAE a prevalence of 3,5% (95% CI:1.9-5.1) of cerebrovascular complication was documented ([@ref5]; [@ref4]).

The morbidity caused by diabetic foot complication is one of the most expensive diabetes (DM) complications to treat. According to one study conducted in Saudi Arabia, the prevalence of diabetic foot was 6% among the diabetic patients and 1.5 % had amputed foot ([@ref1]).

2. Materials & Methods {#sec1-2}
======================

The local directorate of Ministry of Health has granted permission to pursue this study and data were extracted from the patient's records. Despite the fact that there was no direct involvement of the study subjects in this study, ethical approval from the ethical committee of the directorate of Primary health care was taken.

This was a cross sectional retrospective study conducted at 12 chronic disease clinics representing the different geographical areas of Al Ahsa starting the month of Dec 2012-March2013. The study population included all the Type 2 diabetic patients who are registered in the Ministry of Health chronic disease clinics situated in Al Ahsa district of Saudi Arabia and are getting medication on regular basis. This population consisted of around 25701 type 2 diabetic cases. The assumption for sample size determination was 67% prevalence of non compliance (as observed by one study in Al Ahsa of Saudi Arabia), a 95% confidence level with a deviation of ±4% from the true prevalence. To calculate representative sample, we used Epi Info (version 6; November, 1993). With the assumption that the complications in the patients with diabetes could be between 65% and 69% and to achieve the confidence level of 95% we needed 532 persons with diabetes. A systematic random sampling was used to select every third diabetic patient from the daily appointment list attending the chronic disease clinic in the selected health centers. The health records of these diabetic patients attending the 12 chronic disease clinics of Al Ahsa region were screened to document the various complications they are suffering from. The data were collected comprising demographic variables (age, sex and marital status), duration of diabetes, BMI and status of diabetic control (Hb1Ac Level) and chronic complications, The level of glycemic control were defined as optimal (HbA1c \< 6.5%), fair (6.5% ≤ HbA1c ≤ 7.5%), and poor (HbA1c \> 7.5%). The status of obesity was classified according to the international classification based on BMI which were underweight \< 18.5, normal 18.5-24.9, overweight 25-29.9, obesity grade I 30-34.9, obesity Grade II35-39.9 and extreme obesity grade III \>34.

2.1 Complications {#sec2-1}
-----------------

Only chronic complications (categorized as cardiovascular conditions, cerebrovascular conditions, nephropathy, ocular lesions, neuropathy, and diabetic foot problems) that developed after the proper diagnosis of T2DM and could be attributed to diabetes were considered in this study. Cardiovascular morbidity included: hypertension, angina, chronic heart failure, myocardial infarction, other related heart diseases, and peripheral vascular disease; the considered cerebrovascular conditions were stroke and transient ischemic attack (TIA); ocular lesions consisted of retinopathy, cataract and blindness; nephropathy included microalbuminuria, macroalbuminuria, renal hypofunction, and renal failure; and diabetic foot problems presented as foot ulcers or amputation (AMP). According to the involved blood vessels, complications were also stratified into macrovascular complications (all cardiovascular, cerebrovascular and foot diseases) and microvascular complications (nephropathies, neuropathy and eye lesions) ([@ref17]).

Only chronic complications (categorized as cardiovascular conditions, cerebrovascular conditions, nephropathy, ocular lesions, and neuropathy including diabetic foot) that developed after the proper diagnosis of Diabetes Mellitus (DM) and could be attributed to diabetes were considered in this study. Cardiovascular complications included: hypertension and Ischemic Heart Disease (IHD); the considered cerebrovascular conditions included stroke and its complication and transient ischemic attack (TIA); ocular lesions included diabetic retinopathy; nephropathy included microalbuminuria, macroalbuminuria, and renal failure; and neuropathy included painful peripheral neuropathy, painless peripheral neuropathy and diabetic foot problem consisted of superficial foot ulcer, deep foot ulcer or amputation (AMP).

Screening criteria for IHD was either patient with typical cardiac symptoms and abnormal resting ECG or asymptomatic patient with abnormal stress tests, either by ECG or echo and nuclear perfusion imaging test. The presence of diabetic nephropathy was based on the presence of microalbuminuria and abnormally high level of serum creatinine level. Those cases that already have renal failure and are on dialysis or getting treatment for renal failure were included as having suffering from diabetic nephropathy. The patients with stroke were those who have been diagnosed as suffering from stroke at the higher center and were admitted for stroke treatment and were suffering from stroke complication. The diabetic cases who complained of an acute episode of temporary neurologic dysfunction that lasted less than an hour and without any associated tissue infarction of the brain tissue were considered as suffering from TIA.

The reports of the ophthalmologist by regular detailed fundus examination were tagged with the patients' record and were considered for the presence and absence of diabetic retinopathy.

The distal symmetric polyneuropathy screening were performed for each patient of type 2 at diagnosis and yearly afterwards using tests such as pinprick sensation, temperature and vibration perception (Using a 128 Hz tunning fork), 10 gm monofilament pressure sensation at the dorsal surface of both great toes, just proximal to the nail bed and ankle reflexes. The documentation on the patient's record based on these examinations were included in the data. This consisted of normal foot, neuroischemic foot, foot ulcer or amputed foot.

Serum triglyceride level of 150 mg or less was considered as the optimal, 150-199 mg as borderline, 200-499 mg as high and \> 500 mg as very high. Serum cholesterol of 200mg or less was considered as normal while a level of 200-239 mg as borderline and above 240 high as high. Low density lipoprotein C (LDLC) level of 100 or less was considered as the optimal while 100-129 as above optimal, 130-159 as borderline high, 160-189 as high and \>190 as very high. A serum High density lipoprotein C (HDLC) level of 40-60 was considered as desirable while \>60 as High risk.

2.2 Statistical Analysis {#sec2-2}
------------------------

A SPSS 16 version was used for all statistical calculations. Results were expressed as mean values ± SD. For nonparametrical distributions the chi square test was used. A p \< 0, 05 was considered significant all statistical calculations.

3. Results {#sec1-3}
==========

3.1 General Characteristics of Study Population {#sec2-3}
-----------------------------------------------

The medical records of 506 type 2 diabetic subjects could be examined giving a response rate of 95%. Among them were 222 (43.9%) male and 284 (56.1%) female with a mean age of 57.44 years (range 23-88 years). More than fifty percent of them belonged to rural (53%) and the mean duration of diabetes was 10.20 ± 5.96 (range: 1-33 years). Most of the study subjects (89.9%) were married while 5.9% (30) were widow and 4.2% (21) were never married. The mean BMI of the study subjects was 31.43 ± 6.44 (range: 17.8-61.5) \[[Table 1](#T1){ref-type="table"}\].

###### 

Demographic and clinical characteristics of the study population

  Variables                         Percentage                        Number
  --------------------------------- --------------------------------- --------
  **Gender**                                                          
  Male                              43.9                              222
  Female                            56.1                              284
  **Geographic distribution**                                         
  Rural                             53                                268
  Urban                             47                                238
  **Marital Status**                                                  
  Married                           89.9                              455
  Never married                     4.2                               21
  Widow                             5.1                               30
  **Mean age of the participant**   57.44 years (range 23-88 years)   
  **Mean duration of diabetes**     10.20 ±5.96 (range: 1-33 years)   
  **Mean BMI**                      31.43 ± 6.44 (range: 17.8-61.5)   
  **Diabetic control**                                                
  Optimal                           11.1                              56
  Fair                              17.6                              89
  Poor                              71.3                              361
  **Co morbidity Blood Pressure**                                     
  Normal                            52.2                              264
  Hypertension                      47.8                              242
  **BMI**                                                             
  Normal weight                     10.1                              51
  Overweight                        35.8                              181
  Obese Class1                      30.0                              152
  Class2                            12.8                              65
  Class3                            11.3                              57
  **Serum Triglyceride**                                              
  Normal                            57.5                              291
  Borderline                        18                                95
  High                              24.1                              118
  Missing                           0.4                               2
  **Serum Cholesterol**                                               
  Normal                            60.6                              307
  Borderline High                   27.3                              138
  High                              11.7                              59
  Missing                           0.4                               2
  **Serum LDLc**                                                      
  Optimal                           13.8                              70
  Missing                           30.5                              154
  **Serum HDLc**                                                      
  High                              55.7                              282
  Above optimal level               61.3                              310
  Missing                           38.7                              196

Only 11.1% of the diabetic patients were optimally controlled while 17.6% were fairly controlled and 71.3% were poorly controlled. More than fifty percent subjects were obese (30% with class 1, 12.8% with Class 2 and 11.3% with Class 3), 35.8% were overweight and only 10.1% were of normal weight. Serum triglyceride level of 57.9% of the subjects was under normal range while 18% and 24.1% of the subjects were having borderline high and high level of triglyceride respectively. Serum cholesterol level of 60.6% of diabetic patients was optimal while that of 27.3% and 11.7% were at borderline and high level respectively.

The serum LDLc of about 61% (308) of the subjects could be found on their health record which showed that 36.25 % of these subjects were under the optimal level while 68.75% of them showed either high or very high level. Likewise the serum HDLC of 38.7% of the study subjects was not found on the health records. However the HDLC level of all these subjects were under desirable level \[[Table 1](#T1){ref-type="table"}\].

3.2 Prevalence of Chronic Complications {#sec2-4}
---------------------------------------

Overall 72.72% (95% CI 69.78-74.45) of the study subjects were suffering from one or more complications of diabetic mellitus. With regard to the prevalence of chronic complications of Type 2 DM across categories (organ or system), 32.8% (165) of the 506 subjects had single-category complications while there were 25.29% (128) with two and 15% (75) with more than two complications respectively. The single category complication consisted of cardiovascular, renal, diabetic retinopathy, cerebrovascular, diabetic foot and peripheral neuropathy; the prevalence of which were 22.72%, 4.15%, 2.96%, 0.19 %, 2.17 % and 1.38% respectively \[[Table 2](#T2){ref-type="table"}\].

###### 

Prevalence of chronic complications of Type 2 DM across categories (organ or system)

  Variables                                         No of subjects   \%
  ------------------------------------------------- ---------------- --------
  No Complication                                   138              27.28%
  Chronic Complication                              368              72.72%
  **Categories by organ and system**                                 
  Cardiovascular                                    115              22.72
  Hypertension                                      99               19.56
  IHD                                               10               1.98
  Post CBAG                                         2                0.3%
  Heart failure                                     3                0.5
  Renal                                             21               4.15
  Microalbiminuria                                  18               3.56
  Renal failure                                     3                0.6
  Ocular                                            15               2.96
  Early non proliferative diabetic retinopathy      6                1.18
  Moderate Non proliferative diabetic retinopathy   7                1.38
  Proliferative diabetic retinopathy                2                0.59
  Cerebrovascular                                   1                0.19
  Stroke                                            1                0.19
  Diabetic foot                                     11               2.17
  Superficial foot ulcer                            7                1.38
  Deep foot ulcer                                   2                0.39
  Foot amputation                                   2                0.39
  Peripheral Neuropathy                             7                1.38
  Painless sensory neuropathy                       4                0.79
  Painful sensory neropathy                         3                0.59
  Single category                                   169              33.39
  Two category                                      128              25.29
  Three or more                                     75               15.0

The overall prevalence of hypertension, cardiovascular, renal, ocular, cerebrovascular, diabetic foot and peripheral neuropathy were 52.2%, 26.48%, 23.8%, 19.7%, 1.8%, 12.9% and 15.2% respectively. The cardiovascular complication consisted of IHD (118, 23.3%), heart failure (10, 2.0%) and cases with past CBAG surgery (6, 1.2%). The renal complication consisted of 19.6% (99) with microalbiminuria and 4% (20) with renal failure. The ocular complication consisted of early non proliferative diabetic retinopathy, moderate non proliferative diabetic retinopathy and proliferative diabetic retinopathy, the prevalence of which were 13.0% (66), 5.3% (27) and 1.4% (7) respectively. The total subjects with cerebrovascular complication consisted of 1% (5) with TIA and 0.8% (4) with history of stroke. The diabetic foot consisted of 10.9% (55) with superficial foot ulcer, 1.2% (6) with deep foot ulcer and 0.8% (4) with foot amputation. The peripheral neuropathy consisted of 9.6% (48) suffering from symmetric painless sensory neuropathy and 5.7% (29) suffering from painful peripheral neuropathy \[[Table 3](#T3){ref-type="table"}\].

###### 

The overall complication of type 2 diabetics

  Complications                                     No.   \%
  ------------------------------------------------- ----- -------
  **Cardio vascular**                                     
  IHD                                               118   23.32
  Chronic heart failure                             10    1.97
  Post CBAG                                         6     1.85
  Total                                             134   26.48
  Hypertension                                      264   55.2
  **Renal**                                               
  Microalbiminuria                                  99    19.8
  Renal failure                                     20    4.0
  Total                                             119   23.8
  **Ocular**                                              
  Early non proliferative diabetic retinopathy      56    13
  Moderate non proliferative diabetic retinopathy   27    5.3
  Proliferative diabetic retinopathy                7     1.4
  Total                                             90    19.7
  **Cerebrovascular**                                     
  TIA                                               5     1.0
  Stroke                                            4     0.8
  Total                                             9     1.8
  **Diabetic foot**                                       
  Superficial foot ulcer                            54    10.7
  Deep foot ulcer                                   7     1.4
  Foot amputation                                   4     0.8
  Total                                             65    12.9
  **Peripheral neuropathy**                               
  Painless peripheral neuropathy                    48    9.5
  Painful peripheral neuropathy                     29    5.7
  Total                                             77    15.2

3.3 Demographic and Geographic Stratification of Chronic Complications {#sec2-5}
----------------------------------------------------------------------

The overall prevalence of complication among the female subjects was significantly higher than the male (78.16%, 95% CI 76.76-84.40 Vs 65.76%, 95% CI 61.63-69.89, p=.038). This was also true with the single (35.21, 95% CI 31.17-39.49 Vs 29.28%, 95% CI 25.31-3.23, p=.039) double (25.70%, 95% CI 23.32-31.08 Vs 22.97%, 95% CI 19.3-26.6, p=.039) and multiple complications (17.25% 95% CI 12.38 18.7 Vs 13.51%, 95% CI 10.53 -16.49, p=.039) where the prevalence was significantly higher among the females than the males. The prevalence of chronic complication of type 2 diabetes mellitus was higher among the urban population than the rural population (77.3% 95% CI 72.88-80.26 Vs 69.78% 95% CI 66.1%-76.92%, p=.035). Both the single and double complications were significantly more common among the urban while the multiple complications were significantly higher among the rural population than the urban population (16.79%, 95% CI 13.59- 20.11 Vs 12.18%, 95% CI 10 - 12.23) \[[Table 4](#T4){ref-type="table"}\].

###### 

Demographic and Geographic stratification of chronic complications

                                 Gender       Geographic region                                     
  ------------------------------ ------------ ------------------- ------ ------------ ------------- ------
  No complication                76(34.23)    62(21.83)                  54 (22.69)   81 (30.22)    
  Categories of Complication                                                                        
  Single complication            65 (29.28)   100(35.21)          .039   89 (37.39)   80 (29.85)    .035
  Two complications              51 (22.97)   73 (25.70)          .038   66 (27.73)   62(23.14)     000
  Three and more complications   30 (13.51)   49 (17.25)          .039   29(12.18)    45 (16.79)    000
  Total                          146(65.76)   222 (78.16)         .038   184(77.3)    187 (69.78)   .035

3.4 Gender Difference of Co-Morbidity Factors {#sec2-6}
---------------------------------------------

Hyperlipidemia was more prevalent among the female diabetics (45.42 Vs 38.1, p=.295) but the difference was not statistically significant. More than ninety percent of the female were either overweight or obese which was significantly more than the male subjects (91.13%, 95% CI 88.68-93.58 Vs 86.84, 95% CI 83.92-89.76, p=.000). The same was true with the serum cholesterol level which was significantly higher among the female than their male counterpart (40.27, 95% CI 36.04-44.50 Vs 29.58, 95% CI 25.64-33.52, p=.007) \[[Table 5](#T5){ref-type="table"}\].

###### 

Gender difference of co-morbidity factors

  Comorbidity variables    Male, n=222 N(%)   Female, n=284 N(%)   Total n =506 N(%)   P value
  ------------------------ ------------------ -------------------- ------------------- ---------
  **Serum Triglyceride**                                                               .295
   Normal                  136(62.26)         155(54.58)           291 (57.51)         
   Borderline high         39(17.57)          52(18.31)            91(17.99)           
   High                    43(19.37)          75(26.41)            118(23.32)          
   Very High               4(1.8)             2(0.7)               6(1.11)             
  **Blood Pressure**                                                                   .004
   Normal                  143(67.14)         194 (66.22)          337 (66.61)         
   Hypertension            70(32.86)          99(33.78)            169(33.39)          
  **Obesity**                                                                          .000
   Normal weight           28(12.62)          23(8.1)              51(10.08)           
   Overweight              92(41.45)          89(31.34)            181(35.78)          
   Obese Class 1           73(32.88)          79(27.82)            152 (30.04)         
   Obese Class2            15(6.75)           50(20.83)            65(12.84)           
   Obese Class 3           14(6.3)            43(17.60)            57(11.26)           
  **Serum Cholesterol**                                                                .000
   Normal                  156(70.27)         151(53.17)           307(60.67)          
   Borderline high         44(19.82)          96(33.80)            140(27.67)          
   High                    22 (9.91)          37(13.03)            59(11.66)           

4. Discussion {#sec1-4}
=============

The diabetes mellitus is well known for its significant effect on the morbidity and mortality of the population caused by its micro and macro vascular complications resulting in huge burden on the health care system. The knowledge of the epidemiology of its Co-morbidity factors and the prevalence of its complication is very important for formulating the necessary policies and action plan. In the recent years, there have been only a handful small scale studies dealing with the prevalence of chronic complications among diabetes patients attending the Primary health Care facilities of Ministry Of Health in Saudi Arabia. The present study was conducted in the Al Ahsa district of Saudi Arabia and consisted of the entire registered diabetic patient attending all the Primary health care facilities of the ministry of health.

This study has shown that 72.72% of the type 2 diabetic patients were suffering from one or more chronic complication which is lower than that observed in Malaysia (78%) ([@ref1]) but higher than what observed in Libya (68.7%) ([@ref14]) India (60%) ([@ref18]), China ([@ref13]) (52%) and Iran (51.9%) ([@ref2]). However these differences may be due to different methodology and different epidemiological environment.

Unlike our study, Pakistani study ([@ref15]) has found lower percentage of diabetic patients with single complication (17% with single, 33% with two and 35% with three complications). However in Libyan study ([@ref14]), 36.7% had one, 20.1% had two and 11.9% had three and more complication and the same was true with Chinese study ([@ref13]) where 30.5% subjects had single category complication while 15.4% and 6.2 % were suffering from three or more complications respectively. This difference might be due to associated co morbidity and the different duration of diabetes among the diabetic population.

Many studies have found remarkable rural urban differences in the prevalence of type 2 diabetes and so also in its chronic complications ([@ref6]; [@ref19]). The prevalence of Type 2 diabetes in the urban population has been established higher than the rural population and so its complications are also expected to be higher in urban population. With this expectation we have found a higher prevalence of chronic complications (76.57% Vs 72.01, p=.185) among the urban diabetic population than the rural but the same was true in a study conducted in Uzbekistan ([@ref10]) where the researchers have found a higher prevalence of late complications of diabetes in urban population (p\<0.001).

A very high prevalence of obese diabetic (n=274, 54.1%), poorly controlled diabetics (n=361, 71.3%), a higher level of lipidaemia (n=215, 42.9%) and cholesterol (n=199, 39.4%), and a significantly higher prevalence of hypertension (n=264, 52.2%) among the diabetic patients in our study is a matter of concern as they are strong co morbidity factors for further complication.

LDLc and HDLc are the known risk factors for the micro vascular complication especially among the diabetics ([@ref17]). Routine measurement of LDLc and HDLc is required for all the diabetic patients. In this study we have found that the serum LDLc and HDLc level of 39% (197 of 506) of patients were not documented on the health record of the patients and so one of the important risk factors for micro vascular complication is largely unknown.

5. Conclusion {#sec1-5}
=============

We have found a high percentage of chronic complications among the diabetic patients. With the reported high percentage of obesity, hypertension and dyslipidaemia among them as the co morbidity factors which if not controlled can cause an increased number of chronic complication. A high percentage of poorly controlled diabetic subjects is a matter of concern. Lacking lipid profile of the diabetic patients in our study require special attention on the timely investigations of this very important risk factors.
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